Ningbo Newbay Technology Development Co., Ltd

This early-phase study tested a new drug called NB004 in 25 adults with advanced solid tumors that had no standard treatment options. The main goals were to check the drug's safety, side effects, and how the body processes it. The trial was terminated early, so results are limite…